$HROW
HARROW, INC. Stock $hrow

$hrow Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040563 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$36.36M	$34.27M	$22.82M
YoY Change	78.83%	50.13%	21.98%
Cost Of Revenue	$11.30M	$10.07M	$6.721M
YoY Change	83.33%	49.78%	35.86%
Gross Profit	$25.05M	$24.20M	$16.10M
YoY Change	76.88%	50.28%	16.99%
Gross Profit Margin	68.91%	70.62%	70.55%
Selling, General & Admin	$26.21M	$21.03M	$15.42M
YoY Change	72.01%	36.39%	35.8%
% of Gross Profit	104.63%	86.92%	95.77%
Research & Development	$3.336M	$1.421M	$775.0K
YoY Change	374.54%	83.35%	-87.35%
% of Gross Profit	13.32%	5.87%	4.81%
Depreciation & Amortization	$2.883M	$290.0K	$171.0K
YoY Change	276.86%	69.59%	-61.31%
% of Gross Profit	11.51%	1.2%	1.06%
Operating Expenses	$29.55M	$22.45M	$16.20M
YoY Change	85.35%	38.64%	-7.35%
Operating Profit	-$4.495M	$1.744M	-$94.00K
YoY Change	152.81%	-1955.32%	-97.47%
Interest Expense	-$4.708M	$5.749M	$1.800M
YoY Change	86.23%	219.39%	-139.04%
% of Operating Profit		329.64%
Other Income/Expense, Net	-$100.0K	-$4.596M	-$6.335M
YoY Change	-198.04%	-27.45%
Pretax Income	-$9.683M	-$2.852M	-$6.429M
YoY Change	-1017.82%	-55.64%	-22.8%
Income Tax	-$535.0K	$1.539M	$35.00K
% Of Pretax Income
Net Earnings	-$9.148M	-$4.391M	-$6.464M
YoY Change	-967.11%	-32.07%	-22.38%
Net Earnings / Revenue	-25.16%	-12.81%	-28.32%
Basic Earnings Per Share		-$0.13	-$0.24
Diluted Earnings Per Share	-$0.26	-$0.13	-$236.3K
COMMON SHARES
Basic Shares Outstanding	35.12M shares	35.12M shares	27.35M shares
Diluted Shares Outstanding		34.26M shares	27.35M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$82.77M	$73.90M	$49.12M
YoY Change	-18.74%	50.44%	-27.38%
Cash & Equivalents	$74.09M	$65.61M	$44.96M
Short-Term Investments	$8.681M	$8.300M	$4.162M
Other Short-Term Assets	$1.753M	$118.0K	$73.00K
YoY Change	1385.59%	61.64%	-95.86%
Inventory	$10.87M	$8.924M	$5.283M
Prepaid Expenses
Receivables	$36.26M	$18.47M	$6.743M
Other Receivables	$228.0K	$200.0K	$0.00
Total Short-Term Assets	$139.5M	$110.3M	$64.07M
YoY Change	17.95%	72.11%	-29.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.521M	$3.629M	$3.291M
YoY Change	1.0%	10.27%	-65.18%
Goodwill	$332.0K	$332.0K	$332.0K
YoY Change	0.0%	0.0%
Intangibles	$159.9M	$162.7M	$19.63M
YoY Change	574.0%	728.76%
Long-Term Investments			$2.097M
YoY Change
Other Assets		$0.00
YoY Change
Total Long-Term Assets	$172.7M	$175.8M	$34.92M
YoY Change	341.44%	403.43%	199.08%
TOTAL ASSETS
Total Short-Term Assets	$139.5M	$110.3M	$64.07M
Total Long-Term Assets	$172.7M	$175.8M	$34.92M
Total Assets	$312.2M	$286.1M	$98.99M
YoY Change	98.35%	188.98%	-3.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.48M	$6.000M	$7.043M
YoY Change	233.56%	-14.81%	50.78%
Accrued Expenses	$27.79M	$59.00K	$5.307M
YoY Change	130.05%	-98.89%	-8.42%
Deferred Revenue	$75.00K	$153.0K	$115.0K
YoY Change	-33.63%	33.04%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$49.34M	$19.03M	$18.37M
YoY Change	164.83%	3.58%	75.35%
LONG-TERM LIABILITIES
Long-Term Debt	$183.2M	$182.2M	$72.24M
YoY Change	75.83%	152.22%	1.08%
Other Long-Term Liabilities	$9.237M	$9.400M	$7.520M
YoY Change	25.98%	25.0%	62.74%
Total Long-Term Liabilities	$192.4M	$191.6M	$79.76M
YoY Change	72.55%	140.22%	4.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$49.34M	$19.03M	$18.37M
Total Long-Term Liabilities	$192.4M	$191.6M	$79.76M
Total Liabilities	$241.8M	$210.7M	$98.13M
YoY Change	85.77%	114.68%	13.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$133.9M	-$124.8M	-$110.5M
YoY Change	22.29%	12.85%
Common Stock	$35.00K	$35.00K	$27.00K
YoY Change	16.67%	29.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$70.77M	$75.76M	$1.217M
YoY Change
Total Liabilities & Shareholders Equity	$312.2M	$286.1M	$98.99M
YoY Change	98.35%	188.98%	-3.71%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$9.148M	-$4.391M	-$6.464M
YoY Change	-967.11%	-32.07%	-22.38%
Depreciation, Depletion And Amortization	$2.883M	$290.0K	$171.0K
YoY Change	276.86%	69.59%	-61.31%
Cash From Operating Activities	$8.696M	-$1.210M	-$410.0K
YoY Change	-334.27%	195.12%	-80.25%
INVESTING ACTIVITIES
Capital Expenditures	$185.0K	$20.13M	-$1.055M
YoY Change	-78.93%	-2008.06%	265.05%
Acquisitions
YoY Change
Other Investing Activities	-$18.00K	$0.00	-$14.00K
YoY Change	-102.06%	-100.0%	-99.89%
Cash From Investing Activities	-$203.0K	-$20.13M	-$1.069M
YoY Change	3960.0%	1783.07%	-91.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-18.00K	64.20M	0.000
YoY Change	-100.03%		-100.0%
NET CHANGE
Cash From Operating Activities	8.696M	-1.210M	-410.0K
Cash From Investing Activities	-203.0K	-20.13M	-1.069M
Cash From Financing Activities	-18.00K	64.20M	0.000
Net Change In Cash	8.475M	42.86M	-1.479M
YoY Change	-83.48%	-2997.9%	-90.14%
FREE CASH FLOW
Cash From Operating Activities	$8.696M	-$1.210M	-$410.0K
Capital Expenditures	$185.0K	$20.13M	-$1.055M
Free Cash Flow	$8.511M	-$21.34M	$645.0K
YoY Change	-285.42%	-3408.53%	-136.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2022Q3	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001360214
CY2023Q3	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	HROW	Equity In Losses Of Unconsolidated Entity EquityInLossesOfUnconsolidatedEntity		usd
	HROW	Equity In Losses Of Unconsolidated Entity EquityInLossesOfUnconsolidatedEntity		usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	HROW	Stock Issued During Period Value Stock Option Exercised StockIssuedDuringPeriodValueStockOptionExercised		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	HROW	Stock Issued During Period Value Vesting Restricted Stock Units And Public Sector Undertakings StockIssuedDuringPeriodValueVestingRestrictedStockUnitsAndPublicSectorUndertakings		usd
CY2022Q3	HROW	Stock Issued During Period Value Stock Option Exercised StockIssuedDuringPeriodValueStockOptionExercised		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q3	HROW	Stock Issued During Period Value Public Sector Undertakings StockIssuedDuringPeriodValuePublicSectorUndertakings		usd
	HROW	Equity In Losses Of Unconsolidated Entities EquityInLossesOfUnconsolidatedEntities		usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets		usd
	HROW	Purchase Of Product Marketing Authorizations And Patents PurchaseOfProductMarketingAuthorizationsAndPatents		usd
	HROW	Proceeds From Notes Payable1 ProceedsFromNotesPayable1		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt		usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	HROW	Reclassification Of Deferred Financing Costs ReclassificationOfDeferredFinancingCosts		usd
	HROW	Accrual Of Exit Fee Related To Senior Secured Note AccrualOfExitFeeRelatedToSeniorSecuredNote		usd
	HROW	Purchase Of Intangible Asset Included In Accounts Payable And Accrued Expenses PurchaseOfIntangibleAssetIncludedInAccountsPayableAndAccruedExpenses		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent		usd
CY2023Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent		usd
CY2022Q4	HROW	Accrued Managed Care Commercial Rebates AccruedManagedCareCommercialRebates		usd
CY2022Q4	HROW	Accrued Exit Fee For Note Payable Current And Non Current AccruedExitFeeForNotePayableCurrentAndNonCurrent		usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35814
	dei	Entity Registrant Name EntityRegistrantName	Harrow, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-0567010
	dei	Entity Address Address Line1 EntityAddressAddressLine1	102 Woodmont Blvd.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 610
	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37205
	dei	City Area Code CityAreaCode	(615)
	dei	Local Phone Number LocalPhoneNumber	733-4730
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35117746	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65610000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96270000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	8265000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	5589000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18468000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6249000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	8924000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6541000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9011000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3611000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	110278000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	118260000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3629000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3486000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2151000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2112000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	1950000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6972000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7513000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	162703000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23725000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	332000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	332000	usd
CY2023Q3	us-gaap	Assets Assets	286065000	usd
CY2022Q4	us-gaap	Assets Assets	157378000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12772000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	13771000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5319000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4025000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	153000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	113000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	785000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	723000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	19029000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18632000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6735000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7332000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	2713000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	182186000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	104174000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	210663000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	130138000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35117621	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35117621	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29901530	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29901530	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	35000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	30000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	200478000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	137058000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-124756000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109493000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	75757000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27595000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-355000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-355000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	75402000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27240000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	286065000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	157378000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34265000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22823000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93838000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68266000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10067000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6721000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28338000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19218000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	24198000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	16102000	usd
	us-gaap	Gross Profit GrossProfit	65500000	usd
	us-gaap	Gross Profit GrossProfit	49048000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21033000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15421000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	56878000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43004000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1421000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	775000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3316000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2347000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	22454000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	16196000	usd
	us-gaap	Operating Expenses OperatingExpenses	60194000	usd
	us-gaap	Operating Expenses OperatingExpenses	45351000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1744000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-94000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	5306000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	3697000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	5749000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1800000	usd
	us-gaap	Interest Expense InterestExpense	16200000	usd
	us-gaap	Interest Expense InterestExpense	5386000	usd
CY2022Q3	HROW	Equity In Losses Of Unconsolidated Entity EquityInLossesOfUnconsolidatedEntity	3504000	usd
	HROW	Equity In Losses Of Unconsolidated Entity EquityInLossesOfUnconsolidatedEntity	9036000	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	1348000	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1031000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	2676000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4341000	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-5465000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-195000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-344000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4596000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6335000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19333000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18763000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2852000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6429000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14027000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15066000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1539000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1236000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4391000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6464000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15263000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15141000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34255197	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34255197	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27349642	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27349642	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31689947	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31689947	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27293756	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27293756	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10931000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-876000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5941000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15141000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	862000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27240000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	64520000	usd
	HROW	Stock Issued During Period Value Stock Option Exercised StockIssuedDuringPeriodValueStockOptionExercised	85000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	270000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-12971000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11521000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15263000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	75402000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5394000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1932000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6464000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	862000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22052000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	64520000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	18000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-11273000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4476000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4391000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	75402000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15263000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15141000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1095000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1090000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7634000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	541000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	435000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	68000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	36000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2568000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	585000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	2676000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4341000	usd
	HROW	Equity In Losses Of Unconsolidated Entities EquityInLossesOfUnconsolidatedEntities	9036000	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-5465000	usd
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-22000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11521000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5941000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12287000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2309000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2383000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1066000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4079000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	716000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1584000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1534000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1294000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	352000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	40000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	99000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4856000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5417000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	19000	usd
	HROW	Purchase Of Product Marketing Authorizations And Patents PurchaseOfProductMarketingAuthorizationsAndPatents	151084000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1266000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1719000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-152350000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1738000	usd
	HROW	Proceeds From Notes Payable1 ProceedsFromNotesPayable1	4961000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	73552000	usd
	HROW	Payment Of Taxes For Vesting Of Restricted Stock Unit PaymentOfTaxesForVestingOfRestrictedStockUnit	12971000	usd
	HROW	Payment Of Taxes For Vesting Of Restricted Stock Unit PaymentOfTaxesForVestingOfRestrictedStockUnit	876000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	355000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7000	usd
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	55879000	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	59750000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	64520000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	18000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	126546000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-887000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30660000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2792000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	96270000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	42167000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	65610000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44959000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	75000	usd
	us-gaap	Interest Paid Net InterestPaidNet	12279000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4851000	usd
	HROW	Reclassification Of Deferred Financing Costs ReclassificationOfDeferredFinancingCosts	1950000	usd
	HROW	Accrual Of Exit Fee Related To Senior Secured Note AccrualOfExitFeeRelatedToSeniorSecuredNote	2713000	usd
	HROW	Insurance Premium Financed InsurancePremiumFinanced	1321000	usd
	HROW	Insurance Premium Financed InsurancePremiumFinanced	906000	usd
	HROW	Purchase Of Intangible Asset Included In Accounts Payable And Accrued Expenses PurchaseOfIntangibleAssetIncludedInAccountsPayableAndAccruedExpenses	5000000	usd
	HROW	Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses	11000	usd
	HROW	Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses	86000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2188000	usd
	HROW	Consolidation Basis Description ConsolidationBasisDescription	(i) entities in which it holds and/or controls, directly or indirectly, more than 50% of the voting rights
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	18468000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	108000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	73000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	68000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	33000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	108000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4391000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6464000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15263000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15141000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34255197	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34255197	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27349642	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27349642	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31689947	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31689947	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27293756	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27293756	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0881	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0050	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.5396	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0054	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34265000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22823000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93838000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68266000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	153000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	113000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	59000	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	159000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	330000	usd
	HROW	Reimbursable Expenses ReimbursableExpenses	908000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	5289000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3707000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	113000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	38000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3522000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2796000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	8924000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6541000	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	1817000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	858000	usd
CY2023Q3	us-gaap	Prepaid Royalties PrepaidRoyalties	768000	usd
CY2022Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	1165000	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	228000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	139000	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1766000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	937000	usd
CY2023Q3	us-gaap	Supplies Supplies	4314000	usd
CY2022Q4	us-gaap	Supplies Supplies	394000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	118000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	118000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9011000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3611000	usd
CY2023Q3	HROW	Computer Hardware Gross ComputerHardwareGross	1228000	usd
CY2022Q4	HROW	Computer Hardware Gross ComputerHardwareGross	979000	usd
CY2023Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	915000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	860000	usd
CY2023Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4636000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4259000	usd
CY2023Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	6654000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	6449000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13433000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12547000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9804000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9061000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3629000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3486000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	290000	usd
	us-gaap	Depreciation Depreciation	743000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	171000	usd
	us-gaap	Depreciation Depreciation	928000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	2905000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1572000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	1145000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	793000	usd
CY2023Q3	HROW	Capitalized Computer Software Internal Use In Process CapitalizedComputerSoftwareInternalUseInProcess	391000	usd
CY2022Q4	HROW	Capitalized Computer Software Internal Use In Process CapitalizedComputerSoftwareInternalUseInProcess	1333000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2151000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2112000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	172430000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-9705000	usd
CY2023Q3	HROW	Finite Lived Intangible Assets Disposal FiniteLivedIntangibleAssetsDisposal	-22000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	162703000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	15485000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	13771000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12772000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2584000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	398000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7634000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2458000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	13792000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	13792000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	13792000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	13501000	usd
CY2023Q3	HROW	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	105100000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	162435000	usd
CY2023Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	6025000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	6440000	usd
CY2023Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	1221000	usd
CY2023Q3	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	1321000	usd
CY2022Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	575000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	5000000	usd
CY2023Q3	HROW	Accrued Ligitation Settlements Current And Noncurrent AccruedLigitationSettlementsCurrentAndNoncurrent	49000	usd
CY2022Q4	HROW	Accrued Ligitation Settlements Current And Noncurrent AccruedLigitationSettlementsCurrentAndNoncurrent	49000	usd
CY2023Q3	HROW	Accrued Transitional Fees Current And Noncurrent AccruedTransitionalFeesCurrentAndNoncurrent	59000	usd
CY2022Q4	HROW	Accrued Transitional Fees Current And Noncurrent AccruedTransitionalFeesCurrentAndNoncurrent	453000	usd
CY2023Q3	HROW	Accrued Managed Care Commercial Rebates AccruedManagedCareCommercialRebates	2118000	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1979000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1254000	usd
CY2023Q3	HROW	Accrued Exit Fee For Note Payable Current And Non Current AccruedExitFeeForNotePayableCurrentAndNonCurrent	2713000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	13771000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	2713000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	192750000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	110000000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-10564000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-5826000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	182186000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	104174000	usd
CY2023Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.1078	pure
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.1091	pure
CY2022Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0888	pure
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0896	pure
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	5347000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	21159000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	20550000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	159894000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	45030000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	251980000	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	59230000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	192750000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-10564000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	182186000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0660	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y6M14D
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	310000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	921000	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	249000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	622000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	309000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	926000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	309000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	809000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	310000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1262000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1093000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1114000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	972000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	5829000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10580000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3060000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7520000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	785000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6735000	usd
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	1.47
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	25.86
CY2023Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2715092	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y2M4D
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	6.15
CY2023Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2436946	shares
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	5.51
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	493806	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.99
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	54424	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	167253	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	8.13
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	75000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	5.83
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	305977	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	9.96
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4476000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1932000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11521000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5941000	usd
CY2023Q3	HROW	Reduction In Milestone Amounts ReductionInMilestoneAmounts	550000	usd
CY2023Q3	HROW	Reduction In Milestone Amounts ReductionInMilestoneAmounts	550000	usd
CY2023Q3	HROW	Payment For Milestone PaymentForMilestone	4450000	usd
	HROW	Payment For Milestone PaymentForMilestone	4450000	usd

Files In Submission

Name	View Source	Status
hrow-20230930_cal.xml	Edgar Link	unprocessable
0001493152-23-040563-index-headers.html	Edgar Link	pending
0001493152-23-040563-index.html	Edgar Link	pending
0001493152-23-040563.txt	Edgar Link	pending
0001493152-23-040563-xbrl.zip	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
hrow-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
hrow-20230930_def.xml	Edgar Link	unprocessable
hrow-20230930_lab.xml	Edgar Link	unprocessable
hrow-20230930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HROW
HARROW, INC. Stock $hrow

2023 Q4 Form 10-Q Financial Statement

#000149315223040563 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HROW HARROW, INC. Stock $hrow

2023 Q4 Form 10-Q Financial Statement

#000149315223040563 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HROW
HARROW, INC. Stock $hrow